Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
PTN

Palatin

$1.33

-0.02 (-1.48%)

07:20
04/23/18
04/23
07:20
04/23/18
07:20
Syndicate
Palatin enters $25M equity distribution agreement »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
PTN

Palatin

07:06
04/06/18
04/06
07:06
04/06/18
07:06
Initiation
Palatin initiated at H.C. Wainwright »

Palatin initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTN

Palatin

$1.12

0.03 (2.75%)

07:32
04/03/18
04/03
07:32
04/03/18
07:32
Hot Stocks
Palatin presents preclinical oral formulation data on PL-8177 »

Palatin Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTN

Palatin

$1.12

-0.06 (-5.08%)

, AMAG

Amag Pharmaceuticals

$19.25

-0.35 (-1.79%)

08:10
03/26/18
03/26
08:10
03/26/18
08:10
Hot Stocks
Palatin: Amag Pharmaceuticals submits bremelanotide NDA to FDA »

Palatin Technologies…

PTN

Palatin

$1.12

-0.06 (-5.08%)

AMAG

Amag Pharmaceuticals

$19.25

-0.35 (-1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

AMAG

Amag Pharmaceuticals

$19.25

-0.35 (-1.79%)

, PTN

Palatin

$1.12

-0.06 (-5.08%)

08:06
03/26/18
03/26
08:06
03/26/18
08:06
Hot Stocks
Amag Pharmaceuticals submits NDA to FDA for bremelanotide »

AMAG Pharmaceuticals…

AMAG

Amag Pharmaceuticals

$19.25

-0.35 (-1.79%)

PTN

Palatin

$1.12

-0.06 (-5.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

Over a month ago
PTN

Palatin

$0.94

-0.037 (-3.80%)

07:32
02/05/18
02/05
07:32
02/05/18
07:32
Hot Stocks
Palatin begins dosing in first-in-human study of PL-8177 »

Palatin has dosed the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
PTN

Palatin

$0.84

-0.0189 (-2.20%)

07:31
01/03/18
01/03
07:31
01/03/18
07:31
Hot Stocks
Palatin announces FDA clearance of IND application for PL-8177 »

Palatin Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

PTN

Palatin

$0.87

0.0053 (0.61%)

07:36
11/21/17
11/21
07:36
11/21/17
07:36
Hot Stocks
Palatin enters into collaboration with Kwangdong for bremelanotide »

Palatin Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXEL

Exelixis

$24.47

-3.54 (-12.64%)

, PTN

Palatin

09:24
09/25/17
09/25
09:24
09/25/17
09:24
Hot Stocks
On The Fly: Pre-market Movers »

HIGHER: Exelixis (EXEL),…

EXEL

Exelixis

$24.47

-3.54 (-12.64%)

PTN

Palatin

AGN

Allergan

ICPT

Intercept

$61.59

-12.11 (-16.43%)

GPC

Genuine Parts

TGT

Target

LLY

Eli Lilly

AAPL

Apple

$151.89

-1.5 (-0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 18

    Oct

  • 19

    Oct

  • 22

    Oct

  • 30

    Oct

PTN

Palatin

$0.66

0.06 (10.00%)

07:35
09/25/17
09/25
07:35
09/25/17
07:35
Earnings
Palatin reports Q4 EPS 7c, may not compare to consensus (2c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.